TPMT and Decreased total leukocyte count: The low frequency of recognized mutations has limited the detection of meaningful associations with thiopurine treatment response and significant phenotype–genotype correlations; however, the findings in this study emphasize the necessity of assessing the variants in the TPMT gene, establishing it as a standard of care for predicting AZA-related leukopenia.